Stock 1501 SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Shanghai INT Medical Instruments Co., Ltd.

Equities

1501

CNE100003NH7

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:22 2024-04-29 EDT 		5-day change 1st Jan Change
27.65 HKD +0.91% Intraday chart for Shanghai INT Medical Instruments Co., Ltd. +1.47% -3.32%
04-08 Shanghai INT Medical Instruments Seeks Listing on Chinese Bourse MT
03-18 Shanghai INT Medical Instruments Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD. Stock Shanghai INT Medical Instruments Co., Ltd.
-3.32% 613M -
STRYKER CORPORATION Stock Stryker Corporation
+12.07% 128B
A-
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-8.43% 10.65B
A-
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+0.91% 8.82B
C
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
+16.72% 7.19B
C
GLAUKOS CORPORATION Stock Glaukos Corporation
+25.15% 4.99B
B+
AXONICS, INC. Stock Axonics, Inc.
+7.17% 3.4B
C-
ENOVIS CORPORATION Stock Enovis Corporation
-1.36% 3.03B
B-
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-8.73% 2.14B - -
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-10.15% 2B -
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 1501 Stock
  4. Ratings Shanghai INT Medical Instruments Co., Ltd.